MT2015-20: Biochemical Correction of Severe EB by Allo HSCT and Serial Donor MSCs

NCT02582775 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

17

Enrollment

OTHER

Sponsor class

Conditions

Epidermolysis Bullosa

Interventions

DRUG: Thymoglobulin
DRUG: Cyclophosphamide
DRUG: Fludarabine
RADIATION: Total Body Irradiation
PROCEDURE: Bone marrow infusion
DRUG: Tacrolimus
DRUG: Mycophenolate Mofetil
BIOLOGICAL: Donor mesenchymal stem cell infusions
DRUG: Busulfan

Sponsor

Masonic Cancer Center, University of Minnesota